Benefit of Avasopasem Manganese on Severe Oral Mucositis in Head and Neck Cancer in the ROMAN Trial: Unplanned Secondary Analysis.

The predefined sensitivity analyses and exploratory analyses also found consistent highly significant benefit for AVA over placebo in a variety of scenarios testing robustness of the results, with NTB varying in a narrow range from 0.189 to 0.219 ( Table 2 ).

also in 132,142 other papers